Scleroderma in children: emerging management issues

Indian Journal of Dermatology, Venereology and Leprology
Saumya Panda

Abstract

Scleroderma is a set of rare connective tissue diseases of unknown etiology. It is characterized by thickening and hardening of the skin. Scleroderma is divided into two main subgroups: systemic and localized. The systemic form, also known as systemic sclerosis, involves diffuse skin involvement associated with fibrotic changes in internal organs. Juvenile localized scleroderma is a more common entity and is usually confined to a specific region of the body with no internal organ involvement. Therapeutics are divided into three main subgroups for juvenile systemic sclerosis: antifibrotics, anti-inflammatories, and vasodilators. For localized disease, anti-inflammatories, vitamin D analogues, and UV irradiation have been investigated. The rarity of scleroderma in children and the self-limiting nature of the disease together make randomized controlled trials very difficult. Therefore, most data on therapeutic modalities for this condition have to be extrapolated from studies conducted on adults. International cooperation, following a standardized operation protocol, is needed to validate these and future interventions such as autologous stem cell transplant and cytokine-directed therapies.

References

Nov 1, 1988·The British Journal of Dermatology·M J RotheV Falanga
Nov 1, 1982·Archives of Dermatology·J A DoyleR K Winkelmann
Jan 1, 1994·Pediatric Radiology·P LiuR Laxer
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R B SetlowA D Woodhead
May 1, 1993·British Journal of Rheumatology·J J Belch
Aug 15, 1998·Journal of the American Academy of Dermatology·B B CunninghamA S Paller
Aug 15, 1998·Journal of the American Academy of Dermatology·M M SeygerE M de Jong
Jan 15, 2000·The Journal of Pediatrics·Y UzielR M Laxer
Jan 16, 2002·Archives of Dermatology·Allen N Sapadin, Raul Fleischmajer
Jul 20, 2002·Current Rheumatology Reports·James R Seibold
Nov 1, 2002·Current Opinion in Rheumatology·Ivan Foeldvari
Feb 1, 2003·Pediatric Dermatology·Aida PasićDamir Hrsan
Jan 20, 2005·The British Journal of Dermatology·G Mancuso, R M Berdondini
Sep 27, 2005·The British Journal of Dermatology·M DytocL Fiorillo
Dec 22, 2005·Rheumatology·F ZulianUNKNOWN Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES)
Feb 21, 2006·Journal of the American Academy of Dermatology·Alexander KreuterThilo Gambichler
Apr 13, 2006·Paediatric Drugs·Margalit E RosenkranzThomas J A Lehman
Jun 23, 2006·The New England Journal of Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Aug 5, 2006·The Journal of Pediatrics·Francesco ZulianLawrence F Eichenfield
Nov 30, 2006·Arthritis and Rheumatism·Giorgia MartiniUNKNOWN Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society
Dec 21, 2006·Clinical Rheumatology·Ramnath MisraAmita Aggarwal
Dec 28, 2006·Journal of the American Academy of Dermatology·Julia E GravesMichael P Heffernan
Feb 3, 2007·International Journal of Dermatology·M Krishna SumanthTrilokraj Tejasvi
Oct 2, 2007·Arthritis and Rheumatism·Lisa WeibelJohn I Harper
Mar 11, 2008·Rheumatic Diseases Clinics of North America·Francesco Zulian
Oct 7, 2008·Journal of the American Academy of Dermatology·Elisabeth B M KroftElke M G J de Jong

❮ Previous
Next ❯

Citations

Dec 19, 2012·Indian Journal of Dermatology·Aparna Palit, Arun C Inamadar
Mar 16, 2016·Revista chilena de pediatría·Alexis StricklerGonzalo de Toro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.